Search results
Judgment of the Court of First Instance (Fifth Chamber, extended composition) of 26 October 2000. # Bayer AG v Commission of the European Communities.
Judgment of the Court of First Instance (Fifth Chamber, extended composition) of 26 October 2000. Bayer AG v Commission of the European Communities.
BAI and Commission v Bayer Notes on Academic Writings Koenigs, Folkmar: Vorliegen einer gegen den EG-Vertrag verstoßenden Vereinbarung über ein wettbewerbsbeschränkendes Verhalten?, Der Betrieb 2004 p.249 (DE)
Bayer AG. v Commission of the European Communities. (Competition — Parallel imports — Article 85(1) of the EC Treaty (now Article 81(1) EC) — Meaning of 'agreement between undertakings' — Proof of the existence of an agreement — Market in pharmaceutical products) Co. II-3387. Summary of the Judgment. gs. 8. II - 3383. SUMMARY — CASE T-41/96. nc.
4 sty 2024 · Facts. Bayer made and marketed medical drug intended to treat heart disease. As result of differences between national health authorities of MS, prices of these drugs were different across EU, lower in France and Spain. So Spain and France exported great amounts of drugs to the UK.
The Commission held that a tacit agreement existed between Bayer and the wholesalers not to export to the UK contrary to Article 81(1): in its view the agreement was evidenced by the wholesalers ceasing to supply the UK in response to Bayer's tactic of reducing supplies.
APPEAL against the judgment of the Court of First Instance of the European Communities on 29 May 1991 in Case T-12/90 Bayer v Commission [1991] ECR II-219 seeking to have that judgment set aside, the other party to the proceedings being
